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Abstract
Over the last decade, the number of viral genome sequences deposited in available data-
bases has grown exponentially. However, sequencing methodology vary widely and many
published works have relied on viral enrichment by viral culture or nucleic acid amplification
with specific primers rather than through unbiased techniques such as metagenomics.
The genome of RNA viruses is highly variable and these enrichment methodologies may be
difficult to achieve or may bias the results. In order to obtain genomic sequences of human
respiratory syncytial virus (HRSV) from positive nasopharyngeal aspirates diverse method-
ologies were evaluated and compared. A total of 29 nearly complete and complete viral
genomes were obtained. The best performance was achieved with a DNase I treatment to
the RNA directly extracted from the nasopharyngeal aspirate (NPA), sequence-independent
single-primer amplification (SISPA) and library preparation performed with Nextera XT DNA
Library Prep Kit with manual normalization. An average of 633,789 and 1,674,845 filtered
reads per library were obtained with MiSeq and NextSeq 500 platforms, respectively. The
higher output of NextSeq 500 was accompanied by the increasing of duplicated reads per-
centage generated during SISPA (from an average of 1.5% duplicated viral reads in MiSeq
to an average of 74% in NextSeq 500). HRSV genome recovery was not affected by the
presence or absence of duplicated reads but the computational demand during the analysis
was increased. Considering that only samples with viral load E+06 copies/ml NPA were
tested, no correlation between sample viral loads and number of total filtered reads was
observed, nor with the mapped viral reads. The HRSV genomes showed a mean coverage
of 98.46% with the best methodology. In addition, genomes of human metapneumovirus
(HMPV), human rhinovirus (HRV) and human parainfluenza virus types 1–3 (HPIV1-3) were
also obtained with the selected optimal methodology.
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Introduction
Complete genome sequences are a powerful tool for pathogen characterization, molecular sur-
veillance, diagnosis, viral attenuation, response to drug treatment, response to host immune
pressure and even new pathogen discovery [1–5]. In the last years, complete genome sequences
published in databases have grown exponentially along with the development of more sensitive
and faster sequencing technologies [6]. Currently, next generation sequencing (NGS) is one of
the most reliable and most popular technologies for this purpose. One of the most interesting
features of NGS is its ability to obtain detailed information about the pathogen in the sample
just in one test in a relatively unbiased manner [7,8]. The strategy of NGS includes a wet lab
phase in which the target virus can be enriched and a dry lab phase in which an accurate data
analysis pipeline should be developed. The enrichment of the target virus is often carried out
by viral culture or with PCR amplification by using specific primers [9–12]. Nevertheless,
the genome of RNA viruses is highly variable and any kind of enrichment may be difficult to
achieve or may bias the results selecting or enriching some viral variants over others. Cur-
rently, there are many publications which include methodologies to obtain complete viral
genomes trying to avoid bias sources but there are not comparative evaluations among them
[13–18]. The enrichment method used in some of these works was the RNA retrotranscription
and cDNA amplification with random hexamers and in others with SISPA primers. In some
cases, the clinical samples were filtered, treated with DNAse or subjected to a depletion of
rRNA while in other cases combinations of these treatments were used. Each described treat-
ment has been successful, but there is no in-depth analysis of which of them is really necessary.
Furthermore, when working with clinical samples, the available volume is a major constraint.
At the same time, it would be desirable that the number of samples to be sequenced be as large
as possible, even more when molecular surveillance studies are carried out.
Within respiratory viruses, human respiratory syncytial virus (HRSV) is the main viral
cause of acute lower respiratory tract infections in pediatric patients worldwide. The genome
of HRSV is a negative sense ssRNA of approximately 15,200 nucleotides in length, which
includes 10 genes encoding 11 proteins. Currently, several clinical trials with live-attenuated
virus vaccines against HRSV have been reported and most of them are nearing completion,
which makes promising the possibility of preventing the severe disease produced by this virus
in a near future [19]. In this context, the global viral surveillance at the genome level is essential
to verify whether the formulated strain will protect against global and local population of cir-
culating viruses. This is important not only after vaccine implementation but also before to set
a precedent of knowledge about the current ecology of the virus without any vaccine pressure.
In this work, we described an optimized methodology to obtain genomic sequences of
HRSV (subgroups A and B) from clinical samples. We evaluated different sample treatments
in order to enrich the viral RNA extracted from the respiratory clinical samples prior NGS
library preparation. At the same time, we tested variations in the library preparation protocol
to obtain the best performance in an economic manner. Furthermore, we described our bioin-
formatics workflow used for data analysis. Finally, we tested the optimal methodology to
obtain nearly complete genome sequences of other RNA respiratory viruses (human metap-
neumovirus, human rhinovirus and human parainfluenza virus types 1–3).
Materials and methods
Ethics statement
The project was reviewed and approved by the Medical Ethics and Research Committees of
Hospital de Niños “Ricardo Gutie´rrez”, Buenos Aires, Argentina (IRB No. 17.21). Parental
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study design, data collection and analysis, decision
to publish, or preparation of the manuscript. No
additional external funding was received for this
study.
Competing interests: The authors have declared
that no competing interests exist.
informed consent was not obtained because patient information was anonymized and deiden-
tified before analysis.
Clinical samples and RNA extraction
Clinical samples were nasopharyngeal aspirates (NPA) which resulted positive for HRSV by an
indirect immunofluorescence assay as a standard care protocol for respiratory virus routine
diagnosis [20]. Samples were taken from pediatric patients under 2 years of age hospitalized
due to acute lower respiratory tract infection at the Ricardo Gutierrez Children’s Hospital
(HNRG) in Buenos Aires, Argentina during the 2015 and 2016 outbreaks. The samples ana-
lyzed in this study were anonymized and were randomly selected from those that had viral
load higher than E+06 viral copies/ml of NPA. The viral load detection was performed as pre-
viously described [21]. The NPAs were centrifuged at 5,000 g for 5 min to remove cellular
debris. In certain cases, filtration through a 0.22 μm membrane filter was used after centrifuga-
tion to exclude the remaining cellular debris. Viral RNA was extracted from 200 μl of NPA
with PureLink viral RNA/DNA mini kit (Thermo Fisher Scientific) following the manufactur-
er’s instructions except for 2.8 μl of carrier RNA instead of 5.6 μl as recommended to reduce
the presence of tRNA in the extracted RNA. Viral-extracted RNA was eluted in 40 μl of
DNase/RNase-free water and 1.25 μl of 40 U/μL RiboLock RNase Inhibitor (Thermo Fisher
Scientific) were added to preserve the extracted RNA.
DNase treatment
To remove the host DNA from samples, two different DNase treatments were performed: one
was applied to the NPA before the RNA extraction and the other to the extracted RNA.
In the first treatment, 10 U of DNase I plus 20 μl of Buffer 10X with MgCl2 (Thermo Fisher
Scientific) were added to 200 μl of NPA and were incubated at 37 ˚C for 1 hour. The reaction
was stopped with 20 μl of 50 mM EDTA and was incubated at 65 ˚C for 10 min.
The second treatment was performed to 16 μl of the extracted RNA with the addition of 0.1
U of DNase I Amplification Grade (Thermo Fisher Scientific) and 2 μl of 10X Buffer. The reac-
tion mix was incubated at room temperature for 15 min. This reaction was stopped with 2 μl
of 25 mM EDTA and was incubated at 65 ˚C for 10 min.
rRNA depletion
In certain samples, rRNA depletion to the extracted RNA was carried out to evaluate the
decrease of host rRNA by using Ribo-Zero Gold rRNA Removal Kit (Epicentre, Illumina)
according to manufacturer’s instructions.
SISPA (Sequence-independent, single-primer amplification) [22]
Retrotranscription of RNA was performed with SuperScript III Reverse Transcriptase (SSIII)
(Thermo Fisher Scientific). Briefly, 12 μl of viral RNA were mixed with 0.5 μl of 100 μM SIS-
PA-A primer (5'-GTTTCCCAGTCACGATCNNNNNNNN-3') and 1 μl of 10 mM dNTPs. A
denature step at 65 ˚C for 5 min was performed. Then, 4 μl of 5X Buffer, 1 μl of 0.1 mM DTT,
0.5 μl RNase Inhibitor (40 U/μl) and 200 U of enzyme were added (final volume 20 μl). Incuba-
tion conditions were 25 ˚C for 5 min; 50 ˚C for 60 min and 70 ˚C for 15 min.
The second strand cDNA was synthesized with DNA polymerase I, Large Fragment (Kle-
now) (New England Biolabs) by adding to the same tube of the retrotranscription reaction 1 μl
of 10 mM dNTPs, 2 μl of 10X enzyme buffer, 1.5 μl of RNase/DNase-free H2O and 0.5 μl of
enzyme (final volume of 25 μl). No additional primers were added. The incubation conditions
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were a denature step at 94 ˚C for 2 min before the enzyme addition and then 30 min at 37 ˚C
followed by 20 min at 75 ˚C. Finally, the amplification of 5 μl of the double stranded cDNA (ds
cDNA) by using 0.8 μM SISPA-B primer (5'-GTTTCCCAGTCACGATC-3') was performed
with GoTaq DNA Polymerase (Promega) at a final volume of 25 μl following the manufactur-
er’s instructions. Amplification conditions were 95 ˚C for 5 min, followed by 35 cycles of
95 ˚C for 1 min, 65˚C for 1 min and 72 ˚C for 2 min, and a final extension of 72 ˚C for 10 min.
To increase the yield of ds cDNA, the reaction was performed in triplicate.
Random hexamer priming without PCR amplification prior to library
generation
The synthesis of the ds cDNA was performed as described in the previous section but random
hexamers (Qiagen) at a final concentration of 1.6 μM were used instead of SISPA-A primers.
In this case only the retrotranscription with SSIII and the ds cDNA synthesis with Klenow
were performed.
Purification and quantification of DNA
To purify the amplified ds cDNA, the DNA Clean & Concentrator-5 (Zymo Research, Epige-
netics) was used following the manufacturer’s instructions. The ds cDNA was eluted with 12 μl
of Tris-HCl pH 7.5–8.5 to maximize the performance of the elution. The DNA was quantified
with Qubit 2.0 Fluorometer by using Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific).
Library preparation and NGS sequencing
Nextera XT DNA Library Preparation kit (Illumina) was used following manufacturer’s
instructions. Half of the volume of the reagents in the DNA tagmentation and index incorpo-
ration were tested to optimize the yield of the kit. When necessary, a previous ds cDNA dilu-
tion with Tris-HCl pH 7.5–8.5 was performed to reach the required concentration of 0.2 ng/μl
to start the Nextera XT protocol. The clean-up step was performed with 40 μl (0.8X) of Agen-
court AMPure XP beads (Beckman Coulter) to maximize the recovery of fragments of 300 bp
in size. Libraries were quantified by qPCR with NEBNext Library Quant Kit for Illumina
(New England Biolabs) following manufacturer’s protocol. The normalization of the libraries
was carried out manually by diluting each one to the concentration recommended by the
manufacturer. Sequencing was performed in three independent runs, the first one on a MiSeq
platform and the next two on a NextSeq 500. A total of 23 libraries were equimolarly pooled
and were loaded in a 500 cycle MiSeq Reagent Kit v2 (Illumina) and a pair-end sequencing
(2×250 bp) was performed. A total of 40 and 80 libraries were equimolarly pooled in two inde-
pendent runs and were loaded in a 300 cycle mid-output (2x150 bp) NextSeq Reagent kits v2
(Illumina).
Data analysis, genome mapping and consensus sequence obtaining
The quality of the fastq files was evaluated by FastQC tool [23]. To avoid reads with low quality
scores, the PrinSeq tool was used to remove poor quality base calls by trimming 15 nt in the 5’
end and 15 nt in the 3’ end (trim_left 15 trim_right 15) and filtering with a minimum quality
value of 30 (min_qual_mean 30) [24]. The mapping process was performed in two steps by
using BWA software [25]. The first step was to select the most appropriate reference sequence.
For that purpose, a concatenation of genome sequences of different HRSV genotypes previ-
ously published in GenBank was used for a screening mapping. Then, the sequence with the
highest genome coverage was selected as the optimal reference to performed the final mapping
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[26]. Finally, duplicated reads were deleted and consensus sequence was obtained from the
BAM file by using markdup module from SAMtools utilities [27]. Host rRNA contamination
was determined by mapping the filtered reads to human cytoplasmic and mitochondrial rRNA
databases (GenBank accession number NT_167214 and NC_012920, respectively). Host DNA
contamination was evaluated with Kraken software (genome reference GRCh38.p7) [28].
Sanger sequencing
In two samples (HRSV/A/001 and HRSV/B/002), Sanger sequencing was performed by ampli-
fying the viral RNA into 15 overlapped fragments which covered the complete genome by
RT-PCR as previously described [21]. Purified PCR products were labeled with the BigDye
Terminator v3.1 sequencing kit (Applied Biosystems) and were sequenced in an ABI3500
genetic analyzer (Applied Biosystems). The SeqScape Software v2.7 (Applied Biosystems) was
used to analyze, assemble and generate the consensus nucleotide sequences.
Sample nomenclature, methodology and GenBank accession numbers
The sample nomenclature indicates the virus (HRSV: human respiratory syncytial virus;
HMPV: human metapneumovirus; HPIV: human parainfluenza virus types 1–3; HRV: human
rhinovirus), subtype (if available) and the number of the strain (laboratory internal number).
Consensus sequences for each sample are available on GenBank. Accession numbers are
KY883566-KY883572, MG773266- MG773276 and MG839543- MG839547, MG881840.
Different combinations of treatments were named as A to I methodologies (Fig 1). Briefly,
each one included: A- DNase treatment to the NPA, RNA extraction, rRNA depletion, SISPA
and Nextera XT library preparation; B- A methodology without rRNA depletion; C- RNA
extraction, DNase treatment to the RNA, SISPA and Nextera XT library preparation; D- B
methodology with half of the volume of the Nextera XT library preparation; E- C methodology
with half of the volume of the Nextera XT library preparation; F- B methodology with a first fil-
tering-NPA step; G- C methodology with a first filtering-NPA step; H- C methodology with
random hexamer amplification and I- H methodology with half of the volume of the Nextera
XT library preparation.
Results
rRNA depletion (A and B methodologies)
To obtain viral genomic sequences from NPAs two methods (A and B) were evaluated (Fig 1).
The first one included a Dnase I treatment directly to the NPA, a RiboZero treatment to the
extracted RNA and SISPA (A methodology) and was applied to HRSV/A/001 and HRSV/B/
002 clinical samples. At the same time, HRSV/B/002 sample was subjected to B methodology,
which was different from A in which no rRNA depletion was performed. All libraries were pre-
pared with Nextera XT kit and were sequenced on a MiSeq. It is appropriate to mention that
although the DNA concentration of the samples before library preparation was below the rec-
ommended by manufacturer the Nextera XT protocol was followed.
The MiSeq run total yield was 5.9Gb with an error rate of 0.98% and a percentage of bases
with quality score upper or equal to 30 (Q30) of 72.0%. An average of 1.5% of the quality fil-
tered reads mapped against the HRSV reference sequence (Table 1). The genome coverage
was almost complete in the three analyzed libraries even without rRNA depletion (99.7% in
HRSV/A/001-Alibrary and 99.8% in both HRSV/B/002-A and B). Moreover, the depletion of
the rRNA in HRSV/B/002 with the A methodology in comparison to the B one showed a 1.5%
Whole genome RNA virus sequencing methodology
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decrease of rRNA reads. Probably, no substantial difference was observed due to the relatively
low amount of rRNA in the original samples.
The average depth of coverage was 37.6X, 65.3X and 84.7X for HRSV/A/001-A, HRSV/B/
002-A and HRSV/B/002-B, respectively. The A methodology showed a profile of genome
depth of coverage (from now on "coverage profile") with a minimum in the G gene sequence,
which is the highest variable gene of the genome. In contrast, B methodology showed the
highest depth of coverage in the G gene, reflecting a possible bias generated during the rRNA
depletion procedure (Fig 2).
Fig 1. Scheme of sample treatments and library preparation workflow. Different treatments are combined in the methodologies which are denoted
with the letters A to I.
https://doi.org/10.1371/journal.pone.0199714.g001
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Table 1. Comparison of sequencing results applying different methodologies.
Sample copies/ml
of NPA(a)
Methodology
ID(b)
Total
filtered
reads (c)
%mapped reads
to viral
reference(d)
%Duplicated
reads
%genome
coverage(e)
Average depth
of coverage(f)
Min/Max
depth of
coverage
%Reads
aligned to
host(g)
%Reads
aligned to
rRNA(h)
MiSeq sequencing
HRSV/
A/001
1.51E+08 A 469,660 1.27 2.37 99.7 37.60 0/134 78 10.44
HRSV/
B/002
4.13E+08 A 635,184 1.58 3.60 99.8 65.30 0/249 95 13.59
B 796,524 1.50 3.30 99.8 84.70 0/297 96 15.64
NextSeq 500 sequencing
HRSV/
A/003
9.49E+06 B 1,378,092 5.62 91.21 96.5 49.20 0/227 58 20.11
HRSV/
B/004
9.91E+07 B 2,317,914 4.90 93.18 98.6 56.03 0/230 25 24.00
C 1,899,144 10.26 93.63 99.7 89.30 0/234 13 31.01
D 3,054,972 4.86 94.81 96.9 55.60 0/233 19 22.22
E 3,967,890 6.81 96.56 97.2 64.60 0/234 11 30.74
HRSV/
B/005
9.38E+07 F 2,209,306 6.19 95.02 91 49.80 0/237 11 23.08
G 2,121,050 21.66 97.29 99.8 90.50 0/239 18 24.64
HRSV/
B/006
2.38E+08 C 904,954 80.62 98.11 99.7 97.70 0/239 63 9.78
E 4,571,192 79.42 99.51 99.6 124.20 0/240 61 8.87
H 460,408 1.24 34.85 99.4 22.30 0/67 97 9.21
I 2,391,816 1.02 65.84 99.8 50.40 0/119 95 9.59
HRSV/
A/007
2.40E+08 C 200,216 27.33 86.31 96.2 52.14 0/205 83 12.54
E 353,266 30.28 91.75 94.36 59.05 0/223 80 12.77
H 1,315,052 0.03 7.08 53.33 1.74 0/13 99 6.86
I 1,914,840 0.03 13.51 51.72 2.19 0/35 98 14.04
HRSV/
B/008
2.32E+08 C 157,926 11.77 80.18 94.04 25.33 0/192 93 13.44
E 216,860 12.22 86.10 88.75 23.57 0/189 91 13.26
H 1,513,366 0.08 14.32 93.61 6.19 0/25 98 11.99
I 4,150,692 0.07 30.27 93.96 10.99 0/52 97 12.62
HRSV/
A/009
4.53E+07 C 1,170,558 4.91 97.92 99.91 83.73 0/237 75 9.72
E 617,392 41.37 96.44 97.14 61.29 0/237 74 8.95
H 715,448 0.06 5.32 56.69 2.07 0/17 98 11.08
I 1,563,020 0.05 11.93 79.85 3.58 0/22 97 11.43
HRSV/
A/010
3.51E+08 C 357,194 50.62 89.96 99.76 122.23 0/210 50 14.77
HRSV/
B/011
1.28E+08 C 478,062 62.88 95.64 99.93 93.60 0/239 67 17.42
HMPV/
001
1.31E+08 C 1,448,584 1.88 81.82 99.03 36.93 0/179 84 24.22
HMPV/
002
3.94E+07 C 121,464 0.75 15.27 86.82 5.11 0/41 49 9.56
HPIV1/
001
6.14E+07 C 981,338 0.99 77.13 62.86 15.02 0/139 93 80.00
HPIV1/
002
2.84E+09 C 1,066,666 68.06 97.29 99.9 143.09 0/236 49 15.20
HPIV2/
001
5.51E+10 C 1,838,012 82.36 98.41 100 178.92 2/230 47 14.00
HPIV2/
002
1.43E+08 C 518,934 18.02 90.01 96.67 64.79 0/181 36 10.34
HPIV3/
001
1.97E+08 C 528,358 35.63 93.92 98.12 81.60 0/211 48 10.09
(Continued)
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The analysis of host DNA percentage revealed that more than 75% of the reads of each
library mapped to human DNA despite the DNase I treatment (78% in case of HRSV/A/001;
95% and 96% in case of HRSV/B/002-A and HRSV/B/002-B, respectively).
To evaluate the reliability of the methodology, we sequenced the samples HRSV/A/001
and HRSV/B/002 by Sanger. The nucleotide sequences for each sample were identical by
both Sanger and NGS sequencing (GenBank accession number: KY883567 and KY883569),
but NGS sequencing with SISPA covered more nucleotide bases from 5’ and 3’ end of the
genomes.
An improvement of RSV genome sequencing approach (C to I
methodologies)
Different treatment combinations were evaluated to improve the sensitivity and specificity in
HRSV sequencing reducing the percentage of human genome reads, improving the coverage
profile across the genome and to increasing the cost-effectiveness as much as possible (Fig 1).
Based on previous results, no rRNA depletion was considered for the new procedures. In this
opportunity, all the libraries were sequenced on a NextSeq 500 platform in two independent
runs. In the first run, the total yield was 38.6Gb with an error rate of 0.63% and 87.0% of the
reads with Q30. The total yield in the second run was 59.3 Gb with an error rate of 2.29%
and 68.7% of the reads with Q30.
Evaluation of DNase I treatment. To reduce the percentage of human genome reads,
extracted RNA instead of NPA was treated with DNase I (C methodology). HRSV/B/004 was
subjected to both B and C methods. The host contamination analysis showed that DNase I
treatment to the extracted RNA was remarkably more efficient than to the NPA (Table 1). The
reduction of host reads (from 25% to 13%) allowed to increase specific HRSV reads more than
twice as the B methodology (from 4.90% to 10.26%).
At this point, it is important to mention that the use of a NextSeq 500 platform increased
the capability to generate data; but in our experience this increment was related to the genera-
tion of many duplicated reads and most of them belonged to the G gene. For example, the
HRSV/B/004-B library had an average depth of coverage for the G gene of 191.1X (minimum:
109X and maximum: 230X) but before removal of duplicated reads from the alignment it had
Table 1. (Continued)
Sample copies/ml
of NPA(a)
Methodology
ID(b)
Total
filtered
reads (c)
%mapped reads
to viral
reference(d)
%Duplicated
reads
%genome
coverage(e)
Average depth
of coverage(f)
Min/Max
depth of
coverage
%Reads
aligned to
host(g)
%Reads
aligned to
rRNA(h)
HPIV3/
002
9.34E+08 C 9,293,908 95.37 99.70 99.98 204.30 0/241 44 0.30
HRV/C/
001
9.59E+07 C 1,146,828 19.67 95.62 98.21 123.76 0/185 28 9.09
(a) NPA: nasopharyngeal aspirate.
(b) Description of A-H methodologies are in the manuscript and Fig 1.
(c) Reads were filtered according quality scores upper or equal than 30.
(d) For HRSV, GenBank accession number of the reference sequences are KU950583 for subtype A and JX576745 for subtype B; for HMPV is KF530179; for HRV is
GU219984; for HPIV are KF530212, MF077313 and KJ672618 for types 1, 2 or 3, respectively.
(e) Percentage regarding the length of each the reference sequence.
(f) Average depth of coverage was calculated without duplicated reads.
(g) Human reference: GRCh38.p7.
(h) Human cytoplasmic and mitochondrial rRNA: NT_167214 and NC_012920.
https://doi.org/10.1371/journal.pone.0199714.t001
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an average depth of coverage of 9464.8X with a minimum of 448X and a maximum of 23263X
(more information of the samples in S1 Table).
Evaluation of half amount of library preparation reagents. To increase the yield of
library preparation reagents, the reactions of cDNA tagmentation and index incorporation
were scaled down to half of the volume recommended by the manufacturer’s protocol [29,30].
The clean-up was performed according to the Agencourt AMPure XP beads protocol and
normalization of libraries was performed manually, as was done with all methodologies. This
reduction of reagents was tested either with DNase I treatment to the NPA or to the RNA
(identified as D and E methodologies, respectively). The average depth of coverage was similar
to those obtained with standard reaction volumes (55.6X, min/max: 0/233 for HRSV/B/004-D
and 64.6X, min/max:0/234 for HRSV/B/004-E) and the coverage profiles were also similar.
Thus, the reduction of reagents is possible and it allows increasing the number of libraries that
can be prepared with one Nextera XT Kit (Table 1 and Fig 2).
Evaluation of 0.22 μm filtering. To test another approach to avoid the high presence of
host DNA, the NPA was filtered with 0.22 μm pore-size membrane. This methodology was
tested combined either with DNase I treatment to the NPA or to RNA (identified as F and
G, respectively). Both methodologies did not show differences in the percentage of host
DNA (11% vs 18%, respectively); nevertheless, the G methodology increased the recovery
of HRSV reads from 6.19% to 21.66%, which allow the assembly of a complete genome
(Table 1). The main problem with the use of the filter treatment was the loss of volume
of the sample during the procedure, this can be limiting with samples of small volumes such
as pediatrics. Thus, without the use of the filter step, the sequencing of genomes directly
from NPA will be carried out properly if a DNase treatment to the RNA is performed (C
methodology).
Evaluation of random hexamers instead of SISPA primers. We suspected that SISPA
could bias the coverage profile achieved with the different methodologies (A to G), with a
minimum depth coverage at the beginning of the L gene and a maximum in the G gene
(whether or not the duplicated reads were taken into consideration). Thus, random hexamer
amplification was evaluated with the use of either standard and half volume reaction of Nex-
tera XT library preparation reagents (identified as H and I methodologies, respectively).
Four samples were tested (HRSV/B/006, HRSV/A/007, HRSV/A/008, HRSV/B/009) and the
results are listed in Table 1. Only two samples showed good sequencing performance with
around 93% and 99% of the HRSV genome covered (HRSV/B/008 and HRSV/A/006, respec-
tively). The other two samples yielded among 51.82% and 79.85% of the genome covered
with low average depth of coverage. The coverage profiles were different with the random
hexamer amplification; they were more uniformly distributed across the genome than
with SISPA. Nevertheless, the beginning of the L gene remained with low depth of coverage
(Fig 2).
The consensus sequences obtained with SISPA and with random hexamer amplification
were identical for each sample. Nevertheless, PCR step in SISPA is an important step to
increase the HRSV copy number.
Assay of the optimal methodology with other RNA viruses. From all the methodologies,
the C one was the optimum (Fig 1). Thus, it was used for sequencing other respiratory RNA
viruses present in NPA positive samples for human metapneumovirus (HMPV), human rhi-
novirus C (HRV-C) and human parainfluenza virus types 1, 2 and 3 (HPIV1-3). Complete and
nearly complete genome sequences were obtained. The viral loads of the different respiratory
viruses in the clinical samples were upper than E+07 viral copies/ml. Detailed information of
sequencing performance is shown in Table 1.
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Discussion
The methodology described in this work proved to be robust and accurate. Complete and
nearly complete viral genomes of respiratory RNA viruses were obtained from NPA samples
with both platforms MiSeq and NextSeq 500. No correlation between sample viral loads and
the number of total filtered reads or mapped viral reads was observed.
A limitation of this work is that the small sample volumes obtained from pediatric patients
did not allow subjecting one NPA sample to all the proposed methodologies. In addition, no
other types of clinical samples were evaluated.
Most sequenced HRSV genomes allowed to obtain complete information of all genes, how-
ever some of them could not completely cover the 5 ‘and 3’ ends of the genome, which led the
percentage of genome coverage shown in Table 1 does not reach 100% (e.g.: HRSV/B/006-C in
Fig 2. Coverage profiles of HRSV obtained per sample per methodology. A-I methodologies are indicated at the left of each profile. Genome
organization with genes in green and their coding region in yellow are shown at the top of the figure. Genome regions with depth of coverage upper than
4 are underlined in orange. GenBank accession numbers are indicated in brackets. Only 6 representative samples are shown, other profiles are shown in
S1 Fig.
https://doi.org/10.1371/journal.pone.0199714.g002
Whole genome RNA virus sequencing methodology
PLOS ONE | https://doi.org/10.1371/journal.pone.0199714 June 25, 2018 10 / 15
"% genome coverage" in Table 1 and coverage profile in Fig 2). Similarly, this occurred with
the other analyzed RNA viruses.
The optimal methodology to obtain genomic sequences of RNA viruses by NGS determined
in this work was a DNase I treatment to the RNA directly extracted from the NPA, the retro-
transcription and the amplification performed with SISPA primers and library preparation
performed with Nextera XT DNA Library Prep Kit with manual normalization. Nevertheless,
half amount of library preparation reagents may be used instead of that recommended by
manufacturer.
No rRNA depletion was used as part of the entire protocol due to the low performance
accomplished and taking into account that it is an expensive procedure. In addition, the
obtained coverage profile changed considerably related to all the others, reducing significantly
the coverage of the G gene, one of the main genes used for HRSV genotyping.
Regarding the amplification with random hexamers, stochastic results were obtained inde-
pendently of the viral load of the samples, thus it was defined to continue using SISPA primers,
at least for genomic studies.
Many works on viral metagenomics already exist but no specific one focuses in the compar-
ison of different combinations of treatments for the use in NPA samples to obtain RNA viral
genomes [3,16,26,31,32]. Here, an improvement of the sensitivity and specificity in HRSV
sequencing was evaluated to reduce the percentage of human genome reads, to improve the
coverage profile across the genome and to reduce the cost as much as possible.
Strikingly, as mentioned in the result section, with the use of a NextSeq 500 platform a
higher proportion of duplicated reads was obtained. These duplicated reads could be generated
during the sequencing process or during the final step of SISPA, which was used to increase
the viral copy number and could be revealed with the high output of this platform. In addition,
the duplicated reads increased substantially the computational demand of the genome analysis
when they were considered. From our results, the overall percentage of the HRSV genome
recovery was not affected by the presence or absence of duplicated reads, therefore, they
should be eliminated for the analysis and the high performance of the NextSeq could be used
to pool more genomes per run instead of increasing the depth of coverage of each sample.
Noteworthy SISPA generated a coverage profile with a maximum at the G gene and a mini-
mum at the beginning of the L gene with blank regions in few samples. It has been proposed
that this coverage profile may be an artifact of the specific tag connected at the 5’ end of the N-
octamer present in the SISPA-A primer and later used as SISPA-B primer. This tag could bias
the annealing across the genome favoring the over-amplification of some regions. As was done
by Rosseel et al, stretches of nucleotides of the tag across our genome sequences were mapped
looking for possible annealing and no correlation with over-represented depth of coverage was
found. Even thought, other described sources of bias due to the use of SISPA, as the extension
of the N-oligomer, might have an effect [33]. Several recent studies showed high G gene copy
numbers or highly abundant G mRNA both in vitro and in clinical samples [34–36], providing
a potential source of bias during genome amplification.
A previous work reported that SISPA has the limitation that only works well with a mini-
mum number of E+06 viral particles per ml of sample, otherwise a sample with smaller
amount of viral particles would cause a large number of non-specific amplified sequences [37].
An alternative strategy could be the sequencing of overlapped amplicons that anneal in highly
conserved regions and cover the full HRSV genomes [30]. We are currently working on this
strategy for samples with viral loads under E+06 viral copies /ml of NPA [38]. Nevertheless,
we believe that the use of specific primers designed from pre-existing sequence data might
not detect emergent strains. Thus, we consider of high importance that each region of the
genome should be covered at least twice by different amplicons as was done by Agoti et al [39].
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Complete genome sequences of human metapneumovirus, human parainfluenza types 1–3
and human rhinovirus could be obtained, which support the idea that this methodology is
reproducible in other RNA viruses present in NPA samples.
Finally, assays to harmonize the coverage profile remain pending. Nevertheless, the use of
SISPA may decrease the possibility of specific primer bias and provides the opportunity of
detecting any other known/unknown RNA virus at the same time.
Conclusion
The development of this methodology has great implications for molecular epidemiology
because the enrichment of the viral nucleic acid does not require specific amplification or a
previous step of viral culture, which accelerates the process of genomic characterization of any
new HRSV strain that would emerge. In addition, this methodology demonstrated to be versa-
tile for other RNA viruses from nasopharyngeal aspirates.
The data presented in this work show that a metagenomic approach combined with NGS is
useful for whole genome sequencing of respiratory viruses directly from NPA and would allow
virology laboratories to carry out molecular surveillance programs at the genomic level in real
time.
Supporting information
S1 Fig. Additional coverage profiles obtained per sample per methodology. C, E, H and
I methodologies are indicated at the left of each profile and described in the manuscript.
Sequenced virus and genome length are denoted in pink at the top of the coverages. Genome
regions with depth of coverage upper than 4 are underlined in orange. GenBank accession
number are indicated at the right when appropriate. HRSV: human respiratory syncytial virus,
HMPV: human metapneumovirus, HPIV: human parainfluenza virus (types 1, 2 and 3), HRV:
human rhinovirus.
(JPG)
S1 Table. Minimum (Min), maximum (Max) and average (Avg) depth of coverage with
and without duplicated reads per gene per sample sequenced with C methodology.
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